search
Back to results

Implementation of the Live Donor Champion Program (LDC)

Primary Purpose

End-stage Renal Disease

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Live Donor Champion Program
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for End-stage Renal Disease focused on measuring Live Donor Kidney Transplant, Education, Advocacy, Live Donor

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Waitlist Candidates

Inclusion Criteria:

  • Kidney transplant candidates aged≥18 added to the waitlist in the last year with no potential live donors are eligible.
  • If there is an individual willing to donate, but the candidate is unwilling to consider this option or this particular individual, the candidate is eligible for the trial and may still benefit from identification of new donors or increased comfort accepting donation from others.
  • Participants at University or University of Alabama must speak English. Participants at Northwestern University must speak English or Spanish.

Exclusion Criteria:

  • Candidates with live donors currently under evaluation for donation will be excluded.
  • Those with a previous kidney transplant will be excluded

Live Donor Champions Inclusion Criteria

  • aged≥18
  • English-speaking
  • Be a "Live Donor Champion" (a friend, family member or community member willing to advocate for the wait-listed patient).

Exclusion Criteria

  • <18, not English-speaking

LDC Administrators Inclusion Criteria

  • aged≥18
  • English-speaking
  • Performed tasks related to implementing the LDC program

Exclusion Criteria

  • <18, not English-speaking, and no affiliation with implementing the LDC program

Sites / Locations

  • Washington University in Saint Louis
  • University of Pennsylvania

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Live Donor Champion

Arm Description

The Live Donor Champion program is the sole educational intervention for this trial. LDC consists of 6 monthly sessions of approx. 1 hour each. Each LDC session is led by a transplant physician or clinical coordinator. LDC sessions incorporate formal didactics, active-participant learning, personal stories, moderated group discussions, role-playing, and other skill-building exercises. LDC sessions are as follows: 1) education about ESRD, KT, and LDKT 2) communication skills building 3) Exploring social networks 4) sharing successful donor and recipient stories 5) encouraging candidate self-efficacy 6) Program Recap.

Outcomes

Primary Outcome Measures

Acceptability - Implementation Outcome
Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Acceptability will be measured qualitatively using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Adoption - Implementation Outcome
Adoption is defined as the intention or action to employ an innovation or practice. Adoption will be measured qualitatively using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Appropriateness - Implementation Outcome
Appropriateness is a qualitative measure of the perceived fit, relevance, or compatibility of the innovation for a given setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue. We will measure program appropriateness using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Cost - Implementation Outcome
Cost (incremental or implementation cost) is the cost impact of an implementation effort. Implementation cost will be assessed by estimations made during observational sessions of the intervention.
Feasibility - Implementation Outcome
Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Feasibility will be assessed qualitatively using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Fidelity - Implementation Outcome
Fidelity is defined as the degree to which an intervention was implemented as prescribed in the original protocol or as it was intended by the developers. Fidelity will be qualitatively assessed using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Penetration - Implementation Outcome
Penetration is the integration of a practice within a setting or subsystem. Penetration of the LDC program within our two sites will be measured by calculating the number of eligible persons who use a service, divided by the total number of eligible.
Sustainability - Implementation Outcome
Sustainability is defined as the extent to which a newly implemented treatment is maintained or institutionalized within a service setting's ongoing, stable operations. Sustainability will be qualitatively assessed using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.

Secondary Outcome Measures

Live donor kidney transplantation
Live donor kidney transplantation within one year of enrollment into the study will be collected/identified through electronic medical record system.
Live Donor Inquiries
Live Donor Inquiries on behalf of candidates will be collected/identified through electronic medical record system.
Knowledge of live donation and kidney transplantation
Knowledge of live donation of transplant candidates will be collected during the survey.
Comfort initiating conversations
Comfort initiating conversations with others about live donation will be collected during the survey.

Full Information

First Posted
January 4, 2018
Last Updated
April 14, 2023
Sponsor
Johns Hopkins University
search

1. Study Identification

Unique Protocol Identification Number
NCT03435510
Brief Title
Implementation of the Live Donor Champion Program
Acronym
LDC
Official Title
Implementation of the Live Donor Champion Program
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
May 30, 2018 (Actual)
Primary Completion Date
November 30, 2021 (Actual)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The Live Donor Champion Program is a clinical education program offered to patients placed on the waitlist for kidney transplantation at the Johns Hopkins Comprehensive Transplant Center. The goal of the program is to increase patient knowledge regarding end stage renal disease, kidney transplantation, and live kidney donation and to help patients identify potential live kidney donors. Patients are encouraged to bring family and friends to participate in the program and act as advocates on their behalf. These friends and family members are labeled "live donor champions" and work to assist the patient in spreading awareness about end stage renal disease, kidney transplantation, and live kidney donation. The objectives of this project are to pilot-test and optimize strategies for the dissemination of the Live Donor Champion program in the clinical transplant center setting. The goals of the study are to develop an implementation protocol for centers who want to establish a live donor champion program at their institution.
Detailed Description
Live Donor Champion Concept: Even with adequate education of live donation, many kidney transplant candidates still feel ill equipped to ask others to consider donating. Friends and family are often eager to help and may not be able to serve as donors themselves, but might be able to provide substantial instrumental support. A "Live Donor Champion" (LDC) is a friend, family member, or community member who serves as an advocate for the candidate in their pursuit of live donation. The Johns Hopkins Comprehensive Transplant Center has developed a six-month program that provides education and advocacy training to waitlist candidates and their LDCs. The instrumental support provided by the LDC bridges a critical link between education and action. In pilot studies, candidates with an LDC were more likely to undergo Live Donor Kidney Transplant (LDKT) than matched controls. Using LDCs to increase live donation is a novel approach that has garnered widespread enthusiasm, including support from United Network for Organ Sharing. Live Donor Champions (LDCs) as Instrumental Support for Transplant Candidates. Approaching potential donors is a daunting and overwhelming experience for Kidney Transplant (KT) candidates. Current educational programs address the medical aspects of dialysis, KT, and donation, but neglect the health communication skills to discuss transplantation and to spread awareness through their various social networks. While transplant candidates are hesitant to engage others in conversations about End Stage Renal Disease (ESRD) and live donation, friends, family members, or community members are eager to spread awareness and provide advocacy for the patient. In pilot studies, this intervention improved knowledge regarding LDKT and provided instrumental support to the transplant candidates. Understanding what factors are associated with the successful implementation of this program will enable its eventual dissemination at transplant centers nationwide ultimately improving nationwide education and awareness of LDKT. In order to successfully do so, a scientifically rigorous implementation study is necessary.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
End-stage Renal Disease
Keywords
Live Donor Kidney Transplant, Education, Advocacy, Live Donor

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
210 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Live Donor Champion
Arm Type
Other
Arm Description
The Live Donor Champion program is the sole educational intervention for this trial. LDC consists of 6 monthly sessions of approx. 1 hour each. Each LDC session is led by a transplant physician or clinical coordinator. LDC sessions incorporate formal didactics, active-participant learning, personal stories, moderated group discussions, role-playing, and other skill-building exercises. LDC sessions are as follows: 1) education about ESRD, KT, and LDKT 2) communication skills building 3) Exploring social networks 4) sharing successful donor and recipient stories 5) encouraging candidate self-efficacy 6) Program Recap.
Intervention Type
Behavioral
Intervention Name(s)
Live Donor Champion Program
Other Intervention Name(s)
LDC Program
Intervention Description
Even with adequate education of live donation, many KT candidates still feel ill equipped to ask others to consider donating. Friends and family are often eager to help and may not be able to serve as donors themselves, but might be able to provide substantial instrumental support. An LDC is a friend or family member who serves as an advocate for the candidate in their pursuit of live donation. The Johns Hopkins Comprehensive Transplant Center has developed a 6-month program that provides education and advocacy training to waitlist candidates and their LDCs. The instrumental support provided by the LDC bridges a critical link between education and action.Using LDCs to increase live donation is a novel approach that has garnered widespread enthusiasm.
Primary Outcome Measure Information:
Title
Acceptability - Implementation Outcome
Description
Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Acceptability will be measured qualitatively using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Time Frame
within 2 years of enrollment
Title
Adoption - Implementation Outcome
Description
Adoption is defined as the intention or action to employ an innovation or practice. Adoption will be measured qualitatively using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Time Frame
within 2 years of enrollment
Title
Appropriateness - Implementation Outcome
Description
Appropriateness is a qualitative measure of the perceived fit, relevance, or compatibility of the innovation for a given setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue. We will measure program appropriateness using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Time Frame
within 2 years of enrollment
Title
Cost - Implementation Outcome
Description
Cost (incremental or implementation cost) is the cost impact of an implementation effort. Implementation cost will be assessed by estimations made during observational sessions of the intervention.
Time Frame
within 2 years of enrollment
Title
Feasibility - Implementation Outcome
Description
Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Feasibility will be assessed qualitatively using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Time Frame
within 2 years of enrollment
Title
Fidelity - Implementation Outcome
Description
Fidelity is defined as the degree to which an intervention was implemented as prescribed in the original protocol or as it was intended by the developers. Fidelity will be qualitatively assessed using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Time Frame
within 2 years of enrollment
Title
Penetration - Implementation Outcome
Description
Penetration is the integration of a practice within a setting or subsystem. Penetration of the LDC program within our two sites will be measured by calculating the number of eligible persons who use a service, divided by the total number of eligible.
Time Frame
within 2 years of enrollment
Title
Sustainability - Implementation Outcome
Description
Sustainability is defined as the extent to which a newly implemented treatment is maintained or institutionalized within a service setting's ongoing, stable operations. Sustainability will be qualitatively assessed using an adapted Consolidated Framework for Implementation Research (CFIR) instrument. This instrument will be used during interviews with key stakeholders.
Time Frame
within 2 years of enrollment
Secondary Outcome Measure Information:
Title
Live donor kidney transplantation
Description
Live donor kidney transplantation within one year of enrollment into the study will be collected/identified through electronic medical record system.
Time Frame
within 1 year of enrollment
Title
Live Donor Inquiries
Description
Live Donor Inquiries on behalf of candidates will be collected/identified through electronic medical record system.
Time Frame
within 1 year of enrollment
Title
Knowledge of live donation and kidney transplantation
Description
Knowledge of live donation of transplant candidates will be collected during the survey.
Time Frame
within 6 months of enrollment
Title
Comfort initiating conversations
Description
Comfort initiating conversations with others about live donation will be collected during the survey.
Time Frame
within 6 months of enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Waitlist Candidates Inclusion Criteria: Kidney transplant candidates aged≥18 added to the waitlist in the last year with no potential live donors are eligible. If there is an individual willing to donate, but the candidate is unwilling to consider this option or this particular individual, the candidate is eligible for the trial and may still benefit from identification of new donors or increased comfort accepting donation from others. Participants at University or University of Alabama must speak English. Participants at Northwestern University must speak English or Spanish. Exclusion Criteria: Candidates with live donors currently under evaluation for donation will be excluded. Those with a previous kidney transplant will be excluded Live Donor Champions Inclusion Criteria aged≥18 English-speaking Be a "Live Donor Champion" (a friend, family member or community member willing to advocate for the wait-listed patient). Exclusion Criteria <18, not English-speaking LDC Administrators Inclusion Criteria aged≥18 English-speaking Performed tasks related to implementing the LDC program Exclusion Criteria <18, not English-speaking, and no affiliation with implementing the LDC program
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth King, MD PhD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington University in Saint Louis
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Implementation of the Live Donor Champion Program

We'll reach out to this number within 24 hrs